WNT7B promotes bone formation in part through mTORC1
View abstract on PubMed
Summary
This summary is machine-generated.WNT7B significantly boosts bone formation by increasing osteoblast activity, acting through mTORC1 signaling. This WNT ligand enhances bone mass from embryonic development through adulthood.
Area Of Science
- Bone biology
- Developmental biology
- Molecular signaling
Background
- WNT signaling pathways are crucial for embryonic and postnatal bone development.
- Specific WNT ligands and their downstream effects on osteogenesis remain incompletely understood.
Purpose Of The Study
- To investigate the osteogenic potential of WNT7B and WNT5A in bone formation.
- To elucidate the downstream signaling mechanisms by which WNT7B influences bone mass.
Main Methods
- Engineered mouse models for Cre-dependent expression of WNT7B and WNT5A in osteoblast lineages.
- Utilized Runx2-lineage specific induction for postnatal WNT7B studies.
- Assessed bone mass, osteoblast number, and activity.
- Investigated the role of mTORC1 signaling via Raptor deletion.
Main Results
- Targeted WNT7B induction, but not WNT5A, dramatically increased bone mass.
- WNT7B enhanced osteoblast number and activity, with effects observed from embryonic stages and intensifying postnatally.
- WNT7B activated mTORC1 signaling through the PI3K-AKT pathway.
- Disruption of mTORC1 signaling ameliorated the WNT7B-induced high-bone-mass phenotype.
Conclusions
- WNT7B is a potent stimulator of bone formation.
- WNT7B promotes osteogenesis, at least in part, by activating mTORC1 signaling within the osteoblast lineage.